Antiplatelet Medicine Cards
Important notice: There is currently a lead time of 2 – 4 weeks from date of payment to postage of antiplatelet medicine card orders.
The Antiplatelet Medicine Card has been designed for patients to improve communication about their treatment with antiplatelet medicine.
Combination antiplatelet therapy (with aspirin and, for example, clopidogrel or prasugrel) is established for the prevention of coronary thrombi in patients with coronary artery stents and acute coronary syndromes. The length of the course depends on factors such as the pre-existing clinical condition of the patient, the procedure undertaken and the type of stent deployed.
Inappropriate discontinuation of treatment can occur if there is inadequate communication around the intended duration of combination therapy to the patient and to the primary care physician.
This can increase the risk of intra-stent thrombosis and subsequent myocardial infarction.
Providing patients with written information from an interventional centre on the expected length of therapy may help reduce the incidence of inappropriate discontinuation or prolongation of therapy. The card also provides details on possible adverse effects and potential interactions with other medicine, and highlights the need to consult a doctor before any surgical procedures.
The antiplatelet card has been endorsed by the British Cardiovascular Society and the British Cardiovascular Intervention Society. The cards are free of charge and postage and packaging is payable in advance.
The maximum order at any one given time is 500.
To place an order, please complete the online order form here
Current prices are listed here:
Handbook of Peri-operative Medicines – 3rd edition
The Handbook of Peri-operative Medicines is the first national guidance to professionals working in this area of medicine. Developed collaboratively by clinical pharmacy experts working in the area of Surgery, the Handbook contains information on how medicines are to be managed in the peri-operative period, a time when a patient is nil by mouth and often experiences interruption of medication regimens that are important for the treatment of other non-surgical comorbidities.
It contains information pertaining to the risks and benefits of omitting, changing and continuing therapy during this period, and where possible how those risks can be managed.
The Handbook is an essential guide which will remove the need for individual local guidelines and ultimately reduce variations in patient care and improve outcomes for patients undergoing surgery.
This 3rd edition involves a comprehensive review and revision of the original content, and the addition of over 60 new monographs. New and revised content has been written by Sarah Tinsley, Advanced Clinical Lead Pharmacist Surgical Division at University Hospitals of North Midlands, and Claire Frank, Lead Pre-operative Assessment Pharmacist at Wrexham Maelor Hospital, Betsi Cadwaladr University Health Board.
We are delighted to offer this resource with open access to all – to view, please visit: https://www.ukcpa-periophandbook.co.uk/
The 3rd edition has been endorsed by the Royal College of Physicians and Surgeons of Glasgow, The Preoperative Association and the Royal Pharmaceutical Society.
The Handbook has been funded by UKCPA. Financial support has also been provided by Pfizer Limited as a Medical and Educational Goods and Service, and by a donation from AbbVie Ltd. The pharmaceutical companies have had no input into the content of the Handbook.